SEC Form 4 · accession 0001038133-15-000007
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J McGinley
Officer — Presi, Biologic. & Pharm.
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $18.13 | Dec 31, 2014 | A | 290 | A | Dec 31, 2014 | Dec 30, 2024 | Common Stock | 290 | 290 | D |
| Non-Qualified Stock Option (right to buy)F1 | $18.13 | Dec 31, 2014 | A | 13,710 | A | Dec 31, 2014 | Dec 30, 2024 | Common Stock | 13,710 | 13,710 | D |
Explanation of responses
- F1This option vests and becomes exercisable in monthly equal installments over four (4) years through December 31, 2018.